Granite Point Capital Management, L.P. Axogen, Inc. Transaction History

Granite Point Capital Management, L.P.

$0
Q3 2023

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$6.99 - $10.0 $721,423 - $1.03 Million	-103,208 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$7.26 - $10.7 $175,677 - $258,918	24,198 Added 30.63%	103,208 $819,000
Q4 2021 Feb 11, 2022	SELL	$8.8 - $16.0 $448,712 - $815,840	-50,990 Reduced 39.22%	79,010 $740,000
Q1 2021 May 12, 2021	SELL	$17.18 - $22.6 $6.91 Million - $9.09 Million	-402,433 Reduced 75.58%	130,000 $2.63 Million
Q4 2020 Feb 05, 2021	SELL	$11.5 - $17.96 $555,519 - $867,575	-48,306 Reduced 8.32%	532,433 $9.53 Million
Q3 2020 Nov 06, 2020	BUY	$10.62 - $13.12 $2.58 Million - $3.19 Million	243,239 Added 72.07%	580,739 $6.75 Million
Q2 2020 Aug 12, 2020	BUY	$7.35 - $10.81 $2.48 Million - $3.65 Million	337,500 New	337,500 $3.12 Million
Q1 2020 May 12, 2020	SELL	$8.38 - $17.34 $419,000 - $867,000	-50,000 Closed	0 $0
Q3 2019 Oct 30, 2019	SELL	$12.09 - $20.46 $495,835 - $839,105	-41,012 Reduced 45.06%	50,000 $624,000
Q2 2019 Jul 29, 2019	SELL	$18.5 - $25.47 $1.29 Million - $1.78 Million	-69,864 Reduced 43.43%	91,012 $1.8 Million
Q1 2019 May 14, 2019	BUY	$14.62 - $22.13 $953,326 - $1.44 Million	65,207 Added 68.16%	160,876 $3.39 Million
Q4 2018 Feb 05, 2019	BUY	$17.09 - $38.25 $11,843 - $26,507	693 Added 0.73%	95,669 $1.96 Million
Q3 2018 Nov 13, 2018	SELL	$34.05 - $55.9 $2.86 Million - $4.69 Million	-83,975 Reduced 46.93%	94,976 $3.5 Million
Q2 2018 Aug 13, 2018	SELL	$36.15 - $52.5 $498,870 - $724,500	-13,800 Reduced 7.16%	178,951 $8.99 Million
Q1 2018 May 15, 2018	SELL	$24.4 - $40.25 $1.98 Million - $3.26 Million	-81,000 Reduced 29.59%	192,751 $7.04 Million
Q3 2017 Nov 14, 2017	SELL	$14.65 - $19.35 $316,440 - $417,960	-21,600 Reduced 7.31%	273,751 $5.3 Million
Q2 2017 Aug 10, 2017	BUY	N/A	295,351	295,351 $4.95 Million

Others Institutions Holding AXGN

# of Institutions

130

Shares Held

35.8M

Call Options Held

79.1K

Put Options Held

500

Arrow Mark Colorado Holdings LLC Denver, CO

5.12M
Shares

$68.3 Million
0.49% of portfolio
First Light Asset Management, LLC Edina, MN

3.34M
Shares

$44.6 Million
2.2% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

3.31M
Shares

$44.1 Million
2.42% of portfolio
Black Rock Inc. New York, NY

3.25M
Shares

$43.3 Million
0.0% of portfolio
Morgan Stanley New York, NY

2.52M
Shares

$33.6 Million
0.0% of portfolio

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $564M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Granite Point Capital Management, L.P. with notifications on news.

Account